You are here
ANJIN GROUP, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Generation of a Modified DT_IL3 Fusion Toxin
Amount: $122,830.00DESCRIPTION (provided by applicant): A number of protein fusion toxins, composed of the diphtheria toxin (DT) toxophore and a targeting ligand, have been assembled and tested in Phase I clinical trial ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Further Analysis of a VLS Modified IL-2 Receptor Targeted Toxin
Amount: $147,459.00DESCRIPTION (provided by applicant): The project seeks to further the development of a series of diphtheria toxin mutants which, when employed in the construction of protein fusion toxins, display red ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Modified Diphtheria Toxin IL-7 Fusion Toxins
Amount: $152,141.00DESCRIPTION (provided by applicant): Sweeney et al. (1998) originally reported the construction of DAB389IL-7, a fusion protein based on diphtheria toxin (DT), and proposed that this fusion protein co ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
An IL-2 Receptor Targeted Toxin with Reduced VLS
Amount: $144,786.00DESCRIPTION (provided by applicant): Well over a decade ago the first diphtheria toxin-based fusion protein toxin, DAB389IL-2 (Ontak(R)) was in development as the first of a new class of receptor spe ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health
